Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Osborne

Showing results (541-550 of 560) with videos related to

Pageof 56
Sort By:
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
JNCI Cancer Spectrum|August 12, 2025
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataAdam M Brufsky, Kent F Hoskins, Henry J Conter, et al.
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
Molecular Cancer Therapeutics|November 23, 2012
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilitiesDavid W Craig, Joyce A O'Shaughnessy, Jeffrey A Kiefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Journal of the American Heart Association|January 31, 2024
Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams-Beuren SyndromeDelong Liu, Charles J Billington, Neelam Raja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
Cancer Discovery|May 19, 2017
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsFranklin W Huang, Juan Miguel Mosquera, Andrea Garofalo, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
Molecular Psychiatry|September 10, 2014
Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneityJ Ellegood, E Anagnostou, B A Babineau, et al.
Pageof 56

Showing results (541-550 of 560) with videos related to

Sort By:
Pageof 56
European Urology Oncology|June 10, 2025
A Randomized Controlled Phase 2 Trial Comparing Salvage Radiotherapy for Prostate Cancer Delivered in 4 Versus 2 Weeks (SHORTER): Acute Genitourinary and Gastrointestinal Patient-reported Outcomes at a Single InstitutionHimanshu Nagar, Marshall A Diven, Brady Rippon, et al.
JNCI Cancer Spectrum|August 12, 2025
MammaPrint predicts chemotherapy benefit in HR+HER2- early breast cancer: FLEX Registry real-world dataAdam M Brufsky, Kent F Hoskins, Henry J Conter, et al.
Neuro-Oncology Advances|January 7, 2026
Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningiomaJana Ivanidze, Kellen Vo Vu, Umberto Tosi, et al.
Molecular Cancer Therapeutics|November 23, 2012
Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilitiesDavid W Craig, Joyce A O'Shaughnessy, Jeffrey A Kiefer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 16, 2015
A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Jeremy C Durack, et al.
Journal of the American Heart Association|January 31, 2024
Matrisome and Immune Pathways Contribute to Extreme Vascular Outcomes in Williams-Beuren SyndromeDelong Liu, Charles J Billington, Neelam Raja, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 29, 2023
Joint EANM/SNMMI procedure guideline for the use of <sup>177</sup>Lu-labeled PSMA-targeted radioligand-therapy (<sup>177</sup>Lu-PSMA-RLT)Clemens Kratochwil, Wolfgang P Fendler, Matthias Eiber, et al.
Cancer Discovery|May 19, 2017
Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function <i>ERF</i> MutationsFranklin W Huang, Juan Miguel Mosquera, Andrea Garofalo, et al.
JAMA Oncology|May 24, 2019
Association of Black Race With Prostate Cancer-Specific and Other-Cause MortalityRobert T Dess, Holly E Hartman, Brandon A Mahal, et al.
Molecular Psychiatry|September 10, 2014
Clustering autism: using neuroanatomical differences in 26 mouse models to gain insight into the heterogeneityJ Ellegood, E Anagnostou, B A Babineau, et al.
Pageof 56